• Alligator Bioscience’s nomination committee proposes reducing the board to three members at the extraordinary general meeting on November 27, 2026.
• The committee recommends re-electing Hans-Peter Ostler and Anna Törner, with Hans-Peter Ostler remaining chairman.
• Søren Bregenholt is proposed as a new director; Jörg Möller and Denise Goode are not proposed for re-election.
• Proposed board fees fall 30% to SEK 455,000 for the chairman and SEK 210,000 for each other non-employee director.
• Søren Bregenholt receives no board or committee remuneration while CEO through December 31, 2026; committee fees remain unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on November 13, 2026, and is solely responsible for the information contained therein.